Monte Carlo Simulation for the Radixact™ Tomotherapy Linac Using EGSnrc

Overview

Journal J Med Phys

Date 2024 Nov 11

PMID 39526159

Authors

Danial Seifi Makrani

Hassan Ali Nedaei

Ghazale Geraily

Alireza Khorami-Moghaddam

Nooshin Banaee

Hussam Jassim

Affiliations

Soon will be listed here.

Abstract

Purpose: When exact information regarding the treatment head and initial electron beam is available, the Monte Carlo (MC) approach can properly simulate any linear accelerator. However, manufacturers seldom offer information such as the incident electron beam's energy, radial intensity (spot size), or angular spread. This research aims to forecast these features and verify an MC-simulated linear accelerator model using measurements.

Materials And Methods: The BEAMnrc code simulated a 6 MV photon beam from a Radixact™ Tomotherapy Linac. Percentage depth dose and beam profile calculations were conducted using DOSYXZnrc by various electron energies and spot sizes and compared to measurements using a Gamma index with two distinct criterion sets. Furthermore, the fine-tuned electron energy and spot size profiles were created to minimize any disparities using distinct angle spreads. Finally, the output factors (OFs) for various field sizes were compared.

Results: The MC model's fine-tuned electron energy was determined to be 5.8 MeV, with 88.6% of the calculation points passing the 1%/1 mm test. A circular radial intensity of 1.4 mm best represented the 6 MV photon beam regarding spot size. Furthermore, a mean angular spread of 0.05 reduced the disparity in cross-field profile between computation and measurement. The most considerable disparities between the MC model OFs and observations were 1.5%.

Conclusion: Using the BEAMnrc code, a reliable MC model of the Radixact™ Tomotherapy Linac can be created, as shown in this paper. This model can be used to compute dose distributions with confidence.

References

Chetty I, Curran B, Cygler J, DeMarco J, Ezzell G, Faddegon B . Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys. 2008; 34(12):4818-53. DOI: 10.1118/1.2795842. View

Bhagroo S, French S, Mathews J, Nazareth D . Secondary monitor unit calculations for VMAT using parallelized Monte Carlo simulations. J Appl Clin Med Phys. 2019; 20(6):60-69. PMC: 6560245. DOI: 10.1002/acm2.12605. View

Zhao Y, Mackenzie M, Kirkby C, Fallone B . Monte Carlo calculation of helical tomotherapy dose delivery. Med Phys. 2008; 35(8):3491-500. DOI: 10.1118/1.2948409. View

Almberg S, Frengen J, Kylling A, Lindmo T . Monte Carlo linear accelerator simulation of megavoltage photon beams: independent determination of initial beam parameters. Med Phys. 2012; 39(1):40-7. DOI: 10.1118/1.3668315. View

Quispe-Huillcara B, de-la-Rosa K, Reyes U, Ceron P, Vega H, Sosa M . Characterization of the radiation beam of a tomotherapy equipment with MCNP. Appl Radiat Isot. 2023; 200:110978. DOI: 10.1016/j.apradiso.2023.110978. View

Chen Q, Lu W, Chen Y, Chen M, Henderson D, Sterpin E . Validation of GPU based TomoTherapy dose calculation engine. Med Phys. 2012; 39(4):1877-86. DOI: 10.1118/1.3693057. View

Andreo P . Monte Carlo simulations in radiotherapy dosimetry. Radiat Oncol. 2018; 13(1):121. PMC: 6020327. DOI: 10.1186/s13014-018-1065-3. View

Hussein M, Rowshanfarzad P, Ebert M, Nisbet A, Clark C . A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems. Radiother Oncol. 2013; 109(3):370-6. DOI: 10.1016/j.radonc.2013.08.048. View

Beavis A . Is tomotherapy the future of IMRT?. Br J Radiol. 2004; 77(916):285-95. DOI: 10.1259/bjr/22666727. View

10.

Verhaegen F, Seuntjens J . Monte Carlo modelling of external radiotherapy photon beams. Phys Med Biol. 2003; 48(21):R107-64. DOI: 10.1088/0031-9155/48/21/r01. View

11.

Sheikh-Bagheri D, Rogers D . Sensitivity of megavoltage photon beam Monte Carlo simulations to electron beam and other parameters. Med Phys. 2002; 29(3):379-90. DOI: 10.1118/1.1446109. View

12.

El Naqa I, Pater P, Seuntjens J . Monte Carlo role in radiobiological modelling of radiotherapy outcomes. Phys Med Biol. 2012; 57(11):R75-97. DOI: 10.1088/0031-9155/57/11/R75. View

13.

Hsiao Y, Stewart R, Li X . A Monte-Carlo derived dual-source model for helical tomotherapy treatment planning. Technol Cancer Res Treat. 2008; 7(2):141-7. DOI: 10.1177/153303460800700207. View

14.

Sterpin E, Salvat F, Cravens R, Ruchala K, Olivera G, Vynckier S . Monte Carlo simulation of helical tomotherapy with PENELOPE. Phys Med Biol. 2008; 53(8):2161-80. DOI: 10.1088/0031-9155/53/8/011. View

15.

Ohira S, Takegawa H, Miyazaki M, Koizumi M, Teshima T . Monte Carlo Modeling of the Agility MLC for IMRT and VMAT Calculations. In Vivo. 2020; 34(5):2371-2380. PMC: 7652464. DOI: 10.21873/invivo.12050. View

16.

Kodama T, Saito Y, Hatanaka S, Hariu M, Shimbo M, Takahashi T . Commissioning of the Mobius3D independent dose verification system for TomoTherapy. J Appl Clin Med Phys. 2019; 20(5):12-20. PMC: 6523001. DOI: 10.1002/acm2.12572. View

17.

Jeraj R, Mackie T, Balog J, Olivera G, Pearson D, Kapatoes J . Radiation characteristics of helical tomotherapy. Med Phys. 2004; 31(2):396-404. DOI: 10.1118/1.1639148. View

18.

Gibbons J, Smith K, Cheek D, Rosen I . Independent calculation of dose from a helical TomoTherapy unit. J Appl Clin Med Phys. 2009; 10(1):103-119. PMC: 5720509. DOI: 10.1120/jacmp.v10i1.2772. View

19.

Mackie T . History of tomotherapy. Phys Med Biol. 2006; 51(13):R427-53. DOI: 10.1088/0031-9155/51/13/R24. View

20.

Ruchala K, Olivera G, Schloesser E, Mackie T . Megavoltage CT on a tomotherapy system. Phys Med Biol. 1999; 44(10):2597-621. DOI: 10.1088/0031-9155/44/10/316. View